Singapore markets close in 39 minutes

LLY Mar 2023 310.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
27.000.00 (0.00%)
As of 03:03PM EDT. Market open.
Full screen
Previous close27.00
Open28.15
Bid0.00
Ask0.00
Strike310.00
Expiry date2023-03-17
Day's range25.68 - 28.15
Contract rangeN/A
Volume9
Open interestN/A
  • Reuters

    Eli Lilly sued for age discrimination by U.S. agency EEOC

    Eli Lilly and Co was sued on Monday by the U.S. Equal Employment Opportunity Commission, which accused the drugmaker of illegally refusing to hire older workers for sales representative jobs because of their age. The complaint said Lilly's violations began after Stephen Fry, its senior vice president for human resources and diversity, lamented during an April 2017 "Leadership Town Hall" that its sales force was skewed toward older workers, with 20% fewer "millennials" than the American workforce. According to the EEOC, Fry suggested that the lack of millennials was a problem, and the Indianapolis-based company would target 40% "Early Career" hiring.

  • Zacks

    Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know

    Eli Lilly (LLY) closed the most recent trading day at $307.50, moving -1.27% from the previous trading session.

  • Zacks

    Pharma Stock Roundup: EU Nod to AZN & RHHBY Drugs, FDA Updates for LLY & MRK

    Roche's (RHHBY) eye drug, Vabysmo and AstraZeneca's (AZN) asthma drug Tezspire get approval in Europe. The FDA approves expanded use of Lilly's (LLY) cancer drug, Retevmo.